Bladder Squamous Cell Carcinoma

general

A squamous cell carcinoma of the bladder arising from metaplastic epithelium. It represents less than 10% of bladder carcinomas. The exception is the Middle East along the Nile Valley, where it represents the most common form of carcinoma because of the endemic nature of schistosomiasis. Bladder squamous cell carcinoma is often associated with long-standing chronic inflammation of the bladder and usually has a poor prognosis. The diagnosis of squamous cell carcinoma of the bladder should be

Centers

Active Trials

—

Cancer Funding

Specific Cancer Types(1)

Name	Centers	Active Trials
Metastatic Bladder Squamous Cell Carcinoma	37	37

Top Centers for Bladder Squamous Cell Carcinoma(39)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Winship Cancer InstituteAtlanta, GA NCI Comprehensive High-Volume Research Center	High-Volume Research Center	3	—	71.5
2	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center	High-Volume Research Center	3	—	71.5
3	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive High-Volume Research Center	High-Volume Research Center	3	—	71.5
4	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive High-Volume Research Center	High-Volume Research Center	3	—	71.5
5	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
6	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
7	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
8	UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
9	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
10	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
11	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
12	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
13	UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
14	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
15	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
16	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
17	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
18	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
19	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
20	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	2	—	49.6
21	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
22	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
23	Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
24	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	2	—	49.6
25	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	2	—	49.6
26	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program	Active Research Program	1	—	49.6
27	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	2	—	49.6
28	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program	Active Research Program	2	—	49.6
29	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	2	—	49.6
30	Penn State Cancer InstituteHershey, PA Active Research Program	Active Research Program	2	—	49.6
31	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	2	—	49.6
32	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program	Active Research Program	2	—	49.6
33	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program	Active Research Program	2	—	49.6
34	University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR Active Research Program	Active Research Program	2	—	49.6
35	Northwell Health Cancer InstituteNew York, NY Active Research Program	Active Research Program	2	—	49.6
36	Upstate Cancer CenterSyracuse, NY Active Research Program	Active Research Program	2	—	49.6
37	University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program	Active Research Program	2	—	49.6
38	Louisiana Cancer Research CenterNew Orleans, LA Active Research Program	Active Research Program	2	—	49.6
39	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive		—	—	29.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →